查詢結果分析
相關文獻
- Peficitinib (ASP015K) in Taiwanese Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Disease-modifying Antirheumatic Drugs in a Phase 3 Trial (RAJ3)
- HLA-DQA1 Genotyping in Patients with Rheumatoid Arthritis in Taiwan
- T Cell Receptor Gene Vα and Vβ Usage in Patients with Rheumatoid Arthritis in Taiwan
- Evaluating the Effectiveness of the Coal Ash Artificial Reefs at Wan-Li, Northern Taiwan
- 記臺灣蘭科植物相新記錄種--緣毛松蘭
- 臺灣的氣候變化--氣溫和降水
- Change and Stability in the Dietary System of A Prehistoric: Coastal Population in Southern Taiwan: A Research Design
- Diurnal Vertical Distribution of Ichthyoplankton in I-Lan Bay, NE Taiwan
- 臺灣白鼻心之現況調查
- 《詩經.國風》與《臺灣國風》所隱現之情感教育
頁籤選單縮合
題名 | Peficitinib (ASP015K) in Taiwanese Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Disease-modifying Antirheumatic Drugs in a Phase 3 Trial (RAJ3)=Peficitinib (ASP015K)可減輕臺灣傳統DMARD的反應不佳之類風濕性關節炎患者的疾病症狀:一項Ⅲ期隨機試驗(RAJ3)的事後分析 |
---|---|
作者 | 陳怡行; 田中良哉; 竹内勤; 魏正宗; 方耀凡; 曾瑞成; 井筒裕之; 金子裕一朗; | 書刊名 | 中華民國風濕病雜誌 |
卷期 | 35:2 2021.12[民110.12] |
頁次 | 頁9-27 |
分類號 | 418.2133 |
關鍵詞 | 疾病調節抗風濕藥物; Janus激酶抑制劑; 類風濕性關節炎; 臺灣; Disease-modifying antirheumatic drugs; Janus kinase inhibitors; Rheumatoid arthritis; Taiwan; Peficitinib; |
語文 | 英文(English) |